Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Transdiagnostic Mechanism of Performance Monitoring and Overcontrol in Adolescence: Adaptation and Feasibility

NCT05913557 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05913557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05913557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Transdiagnostic Mechanism of Performance Monitoring and Overcontrol in Adolescence: Adaptation and Feasibility
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
August 11, 2020
Completion date
February 28, 2022
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia nervosa, depression, anxiety, obsessive-compulsive disorder, social phobia